Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model
- 28 February 1995
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 160 (2), 257-263
- https://doi.org/10.1016/0008-8749(95)80036-i
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-γ) and tumour necrosis factor-alpha (TNF-α) on human renal cell carcinomaClinical and Experimental Immunology, 1994
- Immunotherapy of renal cell carcinomaCA: A Cancer Journal for Clinicians, 1993
- Interleukin-4 and Cancer TherapyCancer Investigation, 1993
- Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.Journal of Clinical Investigation, 1993
- An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4Science, 1992
- Interleukin-4-mediated tumor suppression in nude mice involves interferon-γEuropean Journal of Immunology, 1992
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989
- DISPLAY OF THE NEUTRAL GLYCOLIPID GANGLIO-N-TETRAOSYLCERAMIDE (ASIALO GM1) ON CELLS OF THE NATURAL KILLER AND T LINEAGESTransplantation, 1982
- A computer program for comparing K samples with right-censored dataComputer Programs in Biomedicine, 1972